Dr. Emily Gurley
Associate Scientist, Department of Epidemiology
Dr. Emily Gurley is an Associate Scientist in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She has worked in public health research in Bangladesh since 2003, and she spent 12 years at the icddr,b (International Center for Diarrheal Diseases Research, Bangladesh) where she led the Surveillance and Outbreak Investigation Unit, and served as Director of the Program on Emerging Infections. She worked closely with the US CDC and the Government of Bangladesh to establish national surveillance for meningoencephalitis, respiratory infections, acute gastroenteritis, acute hepatitis, and hospital-acquired infections, with a focus on developing junior scientists. Dr. Gurley earned her MPH from Emory University in 2002 and a Ph.D. in epidemiology from Johns Hopkins University in 2012.
Dr. Gurley leads multi-disciplinary studies on the transmission, burden, and epidemiology of a variety of emerging and vaccine-preventable diseases, taking into account the ecological context in which human disease occurs. Her interests include improving the communication and collaboration between field epidemiologists and infectious disease modelers and the development of novel surveillance and outbreak detection strategies. She began research to develop strategies for the use of post-mortem tissue sampling as a surveillance tool in Bangladesh in 2008.
Dr. Gurley has published more than 110 peer-reviewed papers and has served on WHO committees to draft recommendations about use hepatitis E vaccines and measurement of dengue infection. She currently serves on WHO’s taskforce for research and development of medical countermeasures against Nipah virus.